Home
Conditions
Leukemia, Myeloid

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,104 public trials 618 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Completed

Symptom-Related Cytokines in Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Patients

NCT00504920

Conditions: Acute Myeloblastic Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: U.T.M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Use and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia Patients

NCT00386373

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +10 more
Locations: U.T.M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Quality of Life of Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)

NCT00459524

Conditions: Acute Myelogenous Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: U.T.M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Zarnestra and Gleevec in Chronic Phase Chronic Myelogenous Leukemia

NCT00040105

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +12 more
Locations: M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Allo Transplantation With Mylotarg, Fludarabine and Melphalan for AML, CML and MDS

NCT00038831

Conditions: Acute Myelogenous Leukemia, Bone Marrow Diseases, Chronic Disease, +20 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Phase I/II Study of 5-Azacytidine With Ara-C in Patients With Relapsed/Refractory Acute Myelogenous Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)

NCT00569010

Conditions: Acute Myelogenous Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: U.T.M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Cytarabine and UCN-01 in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Myelodysplastic Syndrome

NCT00004263

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +9 more
Locations: Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States

University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia

NCT00002833

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +26 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Decitabine and Peripheral Stem Cell Transplantation in Treating Patients Who Have Relapsed Following Bone Marrow Transplantation for Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia

NCT00002832

Conditions: Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +23 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Azacitidine Maintenance Therapy After Allogeneic Bone Marrow Transplantation (Allo BMT)

NCT00350818

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Leukemia, Myeloid

Leukemia, Myeloid trial results

Related conditions